Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kang'ai San
- Development stage
- Preclinical
- Lead developer
- Jilin Changbaishan Pharmaceutical Group
- Administration
- Oral
01
Overview
Kang'ai San (抗癌散) is a traditional Chinese medicine (TCM) formulation used as an adjunct therapy in cancer treatment. While direct, detailed information on "Kang'ai San" specifically is limited in the provided sources, similar TCM anti-cancer formulas such as "Fu Zheng Kang Ai Wan" and "Kang Ai injection" are described as being composed primarily of herbal ingredients like ginseng and astragalus. These formulations are intended to support the immune system, reduce chemotherapy toxicity, improve clinical efficacy, and regulate tumor immune function when combined with standard chemotherapy regimens for cancers such as non-small cell lung cancer (NSCLC)[3][2][6]. The mechanism of action is generally attributed to immunomodulation—enhancing T-cell subsets and natural killer cell activity—and possibly other effects depending on the specific herbal composition. These products are typically developed by Chinese pharmaceutical companies specializing in patent medicines or herbal remedies.
- Brand names
- Kang'ai San
- Other names
- 抗癌散
Beyond the preview
Go deeper on Kang'ai San.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kang'ai San.